Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shumu Decoction + sodium hyaluronate is a combination therapy consisting of a traditional Chinese medicine (TCM) herbal formula, "Shumu Decoction," and the pharmaceutical agent sodium hyaluronate. Sodium hyaluronate is a naturally occurring glycosaminoglycan used as an intra-articular injection or topical agent to relieve pain in osteoarthritis and promote wound healing by acting as a lubricant and shock absorber in joints or as a moisture-retaining agent on skin[1][3][4][5]. Shumu Decoction refers to an herbal blend from TCM, but its precise composition is not standardized in Western literature; similar decoctions are typically used for blood nourishment, circulation improvement, or other systemic effects depending on the specific herbs included[8]. The combination aims to leverage both the symptomatic relief provided by sodium hyaluronate and the systemic or supportive effects attributed to TCM herbal therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shumu Decoction + sodium hyaluronate.